Angel Investor Forum

Angel Investor Forum

Angel Investor Forum launched in 2004 under President David Menard, consolidating a network of accredited individual investors across Connecticut and the broader Northeast to pool capital and expertise into early-stage companies. The group formalizes what was historically an ad-hoc activity for many members, operating under a rigorous screening and presentation model where a curated subset of applicants pitch directly to the full membership at monthly meetings. Members then vote and collectively negotiate term sheets for the companies they choose to back. Investment activity spans seed through Series A rounds, with typical individual member checks ranging from $25,000 to $100,000 and collective round participation that regularly exceeds $250,000. The portfolio crosses enterprise software, digital health, fintech, and industrial technology verticals, with an emphasis on companies that can leverage Connecticut's advanced manufacturing supply chains. Confirmed portfolio holdings include Tangen Biosciences, a molecular diagnostics platform, and ZetrOZ Systems, which develops wearable ultrasound therapeutics — with over $4 million in deployment annually across the membership. The geographic mandate is concentrated in the Northeast corridor, but the group has syndicated rounds extending into the Midwest and Southeast through partner angel networks. The forum operates a structured membership model — new members pay dues and must be accredited investors under SEC standards, though specific member count and individual wealth profiles are not publicly enumerated. The group is a formal chapter of the Angel Capital Association, aligning its diligence standards with national best practices. In May 2024, the forum closed a targeted syndicate round for a Connecticut-based precision-medicine company alongside Connecticut Innovations and an institutional co-investor, reflecting an ongoing emphasis on securing state venture co-investment for portfolio companies (per the firm's official communications, May 2024). What distinguishes Angel Investor Forum from informal metropolitan angel networks is its insistence on full-member voting on every deal and its close operational relationship with Connecticut Innovations, the state's quasi-public venture arm. The group's deal flow funnels through both warm member referrals and a dedicated application portal, but the co-negotiation structure — where the forum presents a single term sheet agreed upon by voting members — gives portfolio companies one negotiation counterpart rather than a dozen individual angels. That architecture attracts founders who value clean cap tables and reduces the coordination risk that fragments many angel syndicates.